KARYOPHARM THERAPEUTICS INC revenue breakdown overview

KARYOPHARM THERAPEUTICS INC revenue for the last year amounted to 140.30 M EUR, the most of which — 140.30 M EUR — came from its highest performing source at the moment, Drugs, the year earlier bringing 132.31 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought KARYOPHARM THERAPEUTICS INC 140.30 M EUR, and the year before that — 132.31 M EUR.